Log in to save to my catalogue

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepato...

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepato...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0be907c2391b401e85670015bfb6cca0

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

There is considerable potential for integrating transarterial chemoembolization (TACE), programmed death-(ligand)1 (PD-[L]1) inhibitors, and molecular targeted treatments (MTT) in hepatocellular carcinoma (HCC). It is necessary to investigate the therapeutic efficacy and safety of TACE combined with PD-(L)1 inhibitors and MTT in real-world situatio...

Alternative Titles

Full title

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0be907c2391b401e85670015bfb6cca0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0be907c2391b401e85670015bfb6cca0

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-022-01235-0

How to access this item